I'm going to attempt something a little odd today, Fools. Even though�Nuverra Environmental Services (NYSE: NES ) stock makes up 1% of my real-life holdings,�I'm going to be giving you three reasons to consider selling the stock today.
Why am I doing this?
Recently, Nobel Prize winner Daniel Kahneman visited Fool headquarters in Virginia. While visiting, he talked about how a number of different biases can lead us to believe we can predict the future with relative certainty. In reality, he argued, we are just deluding ourselves.
It got me to thinking about how I don't write enough about the�risks�of owning the stocks I own. So, though I don't plan on selling my Nuverra stock right now, I think it's healthy for me to practice and model this behavior.
1. Counting on natural gas to be the next big thing
Nuverra is a company whose goal�is to be a one-stop shop to meet all of the water needs of the oil and gas industry. It has set up operations in all of the major shale plays in the United States, and has been building out a massive infrastructure of pipelines, trucking fleets, and water treatment facilities.
Top 5 Stocks To Invest In Right Now: Eurobank Ergasias SA (EUROB)
Eurobank Ergasias SA, formerly EFG Eurobank Ergasias SA, is a banking and financial services group located in Greece. It is organized into five segments: Retail, incorporating customer current accounts, savings, deposits and investment savings products, credit and debit cards, consumer loans, small business banking and mortgages; Corporate, incorporating direct debit facilities, current accounts, deposits, overdrafts, loan and other credit facilities, foreign currency and derivative products to corporate entities; Wealth Management, incorporating private banking services, including total wealth management, to medium and high net worth individuals, insurance, mutual fund and investment savings products, and institutional asset management; Global and Capital Markets, incorporating investment banking services including corporate finance, merger and acquisition and equity brokerage, as well as International. On December 27, 2013, it merged by absorption of the New TT Hellenic Postbank SA. Advisors' Opinion:- [By Corinne Gretler]
National Bank of Greece surged 24 percent and Eurobank Ergasias SA (EUROB) more than doubled. The lenders��planned merger has been postponed and not canceled, Bank of Greece Governor George Provopoulos said, after statements on April 8 that they will be recapitalized separately.
5 Best Trucking Stocks To Own For 2014: Teucrium Wheat Fund (WEAT)
Teucrium Wheat Fund (the Fund) is a commodity pool. The Fund is a series of the Teucrium Commodity Trust (Trust). The Fund provides investors unleveraged direct exposure to wheat without the need for a futures account. The investment objective of the Fund is to have the daily changes in percentage terms of a weighted average of the closing settlement prices for three futures contracts for wheat (Wheat Futures Contracts) that are traded on the Chicago Board of Trade (CBOT), which includes the second-to-expire CBOT Wheat Futures Contract, weighted 35%; the third-to-expire CBOT Wheat Futures Contract, weighted 30%, and the CBOT Wheat Futures Contract, weighted 35%. The Fund is managed by Teucrium Trading, LLC. Advisors' Opinion:- [By Paul Ausick]
The Teucrium Wheat Fund (NYSEMKT: WEAT) closed down 2.43% on Friday to finish the week at $16.47. For the week the fund was up 0.8%. The 52-week range is $13.31 to $19.50. Like corn, the price is up more than 12% since the beginning of the year and down 10.5% over the past 12 months. This fund trades averages just 41,000 shares traded in a day, but nearly tripled that on Friday, when wheat prices fell more than 2% on the CBOT to close at $6.955 a bushel.
5 Best Trucking Stocks To Own For 2014: BHP Billiton Limited(BHP)
BHP Billiton Limited, together with its subsidiaries, operates as a diversified natural resources company worldwide. The company engages in the exploration, development, and production of oil and gas; mining and refining of bauxite into alumina, and smelting of alumina into aluminum metal; and mining of copper, silver, lead, zinc, molybdenum, uranium, gold, diamonds, and titanium minerals, as well as development of potash deposits. It also involves in the mining and production of nickel products, manganese ore, and manganese metal and alloys, as well as in the mining of iron ore, metallurgical coal, and thermal coal. BHP Billiton Limited sells its copper, lead, and zinc concentrates, and alumina to smelters; copper cathodes to wire rod mills, brass mills, and casting plants; uranium oxide to electricity generating utilities; rough diamonds to diamond buyers and diamond manufacturers; nickel products to stainless steel, specialty alloy, foundry, chemicals, and refractory ma terial industries; metallurgical coal to steel producers; and energy coal to power stations, power generators, and industrial users. The company, formerly known as BHP Limited, was founded in 1885 and is headquartered in Melbourne, Australia.
Advisors' Opinion:- [By Alexis Xydias]
Randgold Resources Ltd. (RRS) led commodity producers higher amid signs of growing demand from the world�� second-biggest economy. BHP Billiton Ltd. (BHP) and Rio Tinto Group, the world�� largest mining companies, rallied more than 3 percent. Standard Life Plc (SL/) declined 3.3 percent as analysts raised concern about the insurer�� earnings.
- [By Bruce Kennedy]
The Anglo-Australian mining company BHP Billiton (NYSE: BHP) and Canadian firm Teck Resources (NYSE: TCK) also reported no disruptions at their Chilean mining operations ��although some BHP Billiton personnel were evacuated from port facilities during the tsunami warning.
- [By Reuben Brewer]
Relatively weak demand for thermal coal in China has pushed coal prices lower in Australia. That's a problem for big miners like Rio Tinto (NYSE: RIO ) , BHP Billiton (NYSE: BHP ) , and Peabody Energy (NYSE: BTU ) . However it could add to the allure of uranium miner Cameco (NYSE: CCJ ) .
5 Best Trucking Stocks To Own For 2014: Neogenomics Inc (NEO)
NeoGenomics, Inc. (NeoGenomics) operates a network of cancer-focused testing laboratories. The Company offers testing services, including Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations; immunohistochemistry (IHC) testing, this is the process of identifying cell proteins in a tissue section utilizing the principle of antibodies binding specifically to antigens, and molecular testing, which is a cancer diagnostic tool focusing on the analysis of DNA and ribonucleic acid (RNA), as well as the structure and function of genes at a molecular level.
The cancer testing services, that the Company offers to community-based pathologists are designed to be a natural extension of, and complementary to, the services that they perform within their own practices. In areas where the Company does not provide services to community-based pathology practices, it may directly serve oncology, dermatology, urology and other clinician practices that prefer to have a direct relationship with a laboratory for cancer-related genetic and molecular testing services. NeoGenomics services these types of clients with a global service offering where it performs both the technical and professional components of the tests ordered.
The Company offers tech-only flow cytometry and immunohistochemistry testing services. These types of testing services generally allow the professional interpretation component of a test to be billed separately from the technical component. Its NeoFISH, NeoFLOW and other tech-only service offerings allow properly trained and credentialed community-based pathologists to extend their own practices by performing ! professional interpretations services.
The Company's tech-only services are designed to give pathologists the option to choose, on a case by case basis, whether they want to order just the technical information and images relating to a specific test so they can perform the professional interpretation, or order global services and receive a test report, which includes a NeoGenomics Pathologist�� interpretation of the test results.
The Company also offers a set of global services to meet the needs of those clients who are not credentialed and trained in interpreting genetic tests and who are looking for specialists to interpret the testing results for them. In its global service offerings, its lab performs the technical component of the tests and its doctor of medicine (M.D.s) and doctor of philosophy (Ph.D) s to provide the interpretation services. Its genetic pathology solutions (GPS) report summarizes all relevant case data from its global services on one summary report.
The Company competes with General Electric Healthcare Services and Novartis, A.G.
Advisors' Opinion:- [By John Udovich]
One way or the other, Merrimack Pharmaceuticals Inc (NASDAQ: MACK), Covidien plc (NYSE: COV), NeoGenomics, Inc (NASDAQ: NEO) and�CollabRx Inc (NASDAQ: CLRX) are targeting Barrett's Esophagus�or�esophageal cancer�(the former often leads to the latter) ��a form of cancer that may not be on the top of your list of cancers but is nevertheless on the rise. Approximately 3 million Americans suffer from Barrett's Esophagus, �a condition that�develops as a result of chronic injury from gastroesophageal reflux disease (GERD) where the�normal esophageal lining is replaced with abnormal cells (known as Barrett�� tissue), putting patients at greater risk of developing cancer of the esophagus. And although less than 1% of these patients develop cancer each year, esophageal carcinoma is frequently not detected until later stages, at which point therapy options are limited, extremely invasive, and often ineffective.�This means that�early detection is important�along with�regular surveillance is recommended.�
No comments:
Post a Comment